We acknowledge this Radio NZ follow-up report by Guyon Espiner. We also acknowledge Medical Oncologist, Dr Laird Cameron for his leadership by speaking about the inequity that exists in NZ with access to precision medicines, namely immunotherapy. https://www.rnz.co.nz/news/national/415797/without-keytruda-30-deaths-a-week-in-nz-from-cancer-lung-foundation?fbclid=IwAR0IrzmOPsZ7mE3g5B4Du-2lhQC4_5Ly5pY8mqSPjaFQmL5jOW56YVi_hbA
May, 2020
Letter to Pharmac from Prof. Tony Mok, a world-renowned expert in precision medicine for lung cancer.
Professor Tony Mok of Hong Kong wrote to Pharmac in support of Lung Foundation New Zealand, because he was deeply concerned to hear the proposed Request for Proposal (RFP) for non-small cell lung cancer (NSCLC) has been further delayed. Click to view his letter – CU Medicine-active link
